Alternate TextTo enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.
Home > Products

Products

You can also try the following methods, and our professionals will serve you Customized Consultation
Cat. No. Product Name Field of Application Chemical Structure
DCC4417 Rhlr Agonist S4
Quorum sensing modulator as a RhlR agonist
More description
DCC4416 Rhizoxin
Potent tubulin assembly and cancer cell growth inhibitor
More description
DCC4415 Rh-5849
Novel Insect growth regulator, as potential insecticide to control olive fruit fly (Bactrocera oleae Rossi)
More description
DCC4414 Rh02007
Novel inhibitor of the human papillomavirus (HPV) E6 oncoprotein
More description
DCC4413 rh01617
Potent inhibitor of Kv1.5 potassium channel
More description
DCC4412 Rgia-5524
Novel Potent and Stable Antagonist of the Human α9α10 Nicotinic Acetylcholine Receptor for the Treatment of Neuropathic Pain
More description
DCC4411 rgh-237
Orally active, selective dopamine D3 receptor partial agonist
More description
DCC4410 Rgd-ss-ca
Novel peptide-drug conjugate, inducing significant tumor growth suppression with negligible toxicity
More description
DCC4409 Rgd-mimetic-1
Novel avß6 selective arginyl-glycinyl-aspartic acid (RGD)-mimetic, demonstrating to bind with extremely high affinity and selectivity for the alphavß6 integrin and having the potential as a clinical tool and therapeutic for investigating the role of avß6
More description
DCC4408 Rgb-286147
Potent, selective & ATP-competitive inhibitor of Cdks
More description
DCC4407 Rg7388-tco
Highly Potent Clickable Probe for Cellular Imaging of MDM2 and Assessing Dynamic Responses to MDM2-p53 Inhibition
More description
DCC4406 Rg-102240
Gene switch ligand as a transcription inducer for use in induceable gene expression systems
More description
DCC4405 Rf470dl
Novel fluorescent D-amino acid for labeling peptidoglycans (PG) in live bacteria
More description
DCC4404 Rf3286
Novel Highly Selective Neuropeptide FF1 Receptor Antagonist, Potently Preventing Opioid-Induced Hyperalgesia
More description
DCC4403 Rf04289
Novel TLR2 activator
More description
DCC4402 Reveromycins Inducer Br-1
Novel biomediator that induces reveromycins production at the wide range of concentrations without affecting cell growth
More description
DCC4401 Revamilast
Novel phosphodiesterase IV (PDE4) inhibitor for the treatment of Asthma and Rheumatoid Arthritis
More description
DCC4400 Rev1/ubm2 Inhibitor
Novel inhibitor of the REV1/UbPCNA interaction, directly binding to REV1 UBM2 and preventing DNA damage tolerance (DDT)
More description
DCC4399 Retro-2.1
Novel potent inhibitor of EBOV infection and entry
More description
DCC4398 Resveratrol-4’-sulfate
Metabolite of Resveratrol
More description
DCC4397 resveratrol-3-sulfate
Metabolite of Resveratrol
More description
DCC4396 Resorufin-r1
Red-absorbing, water-soluble, and iodinated resorufin derivative, being selectively activated with a monoamine oxidase (MAO) enzyme, showing high 1O 2 generation yields in aqueous solutions upon addition of MAO isoforms
More description
DCC4395 Resorcinolnaphthalein
Angiotensin-converting enzyme 2 (ACE2) activator, acting as a modulator on RAAS and KKS activation during COVID-19
More description
DCC4394 Resiniferatoxin
Potent VR1 vanilloid receptor agonist, activating protein kinase C
More description
DCC4393 Resazurin
Oxidation-reduction indicator in cell viability
More description
DCC4392 Repinotan Hydrochloride
Selective 5-HT1A receptor agonist
More description
DCC4391 Rep8839
Novel bacterial methionyl t-​RNA synthetase (MRS) inhibitor, hampering Plasmodium growth very effectively
More description
DCC4390 Renzapride Hydrochloride
5-HT3 antagonist and 5-HT4 agonist, also acting as a 5-HT2B antagonist
More description
DCC4389 Remifentanil
Potent ultra short-acting synthetic unique opioid analgesic
More description
DCC4388 Remeglurant
Novel selective antagonist of the mGlu5 receptor
More description

Customized Consultation X

Your information is safe with us. * Required Fields.

Your name
Company
Email
Procuct Name
Cat. No.
Remark
Verification code
Please fill out the characters in the picture
X